Economic evaluation in asthma care
Read Online
Share

Economic evaluation in asthma care methodological issues in measuring costs and outcomes and a review of recent studies by Lynda McKenzie

  • 66 Want to read
  • ·
  • 32 Currently reading

Published by Health Economics Research Unit, University of Aberdeen in Aberdeen .
Written in English


Book details:

Edition Notes

Statementby Lynda McKenzie.
SeriesDiscussion paper / Health Economics Research Unit -- no.04/97, Discussion paper -- no.04/97.
ContributionsUniversity of Aberdeen. Health Economics Research Unit.
The Physical Object
Pagination53p. ;
Number of Pages53
ID Numbers
Open LibraryOL17386296M

Download Economic evaluation in asthma care

PDF EPUB FB2 MOBI RTF

Economic evaluation may be conducted on varied aspects of asthma programs, and its scope may vary from being a comprehensive evaluation of a major asthma intervention, service, or strategy, to being a targeted evaluation of a single aspect of an activity. We use the generic term “program” to refer to any of these examples. Special Article from The New England Journal of Medicine — An Economic Evaluation of Asthma in the United States Red Book, 14 after deflating the costs to about asthma care, costs Cited by: The costs and effectiveness of asthma action plans for children were evaluated in a cross-sectional economic analysis. Direct health care and indirect costs, nights with symptoms, and asthma attacks were measured in Ontario children with by: In this randomized controlled economic evaluation we compared guided asthma self-management with usual asthma care according to guidelines for Dutch family physicians. Nineteen family practices were randomized, and adults with stable asthma (98 self-management, 95 usual care) were included and monitored for 2 years.

In this randomized controlled economic evaluation we compared A systematic review including 23 trials concluded that self-guided asthma self-management with usual asthma care according management programs are able to improve health outcomes to guidelines for Dutch family physicians. To the Editor: Weiss et al. (March 26 issue)* convincingly show that both lives and money will be saved by improving the home treatment of patients with asthma. Practically, this involves education. The new edition of Methods for the Economic Evaluation of Health Care Programmes equips the reader with the necessary tools and understanding required to undertake evaluations by providing an outline of key principles and a 'tool kit' based on the authors' own experiences of undertaking economic ng on the strength of the previous edition, the accessible writing style ensures the .   Treatment decisions are generally best based upon clinical appearance and serial evaluation. Assumption that an asthma patient has asthma (rather than, for example, pneumothorax or pneumonia). Bedside BLUE-protocol ultrasound exam will go a long way to avoid this mistake. The Internet Book of Critical Care is an online textbook written by.

  The evaluation of the cost of asthma from both a social and economic perspective is necessary for an optimal allocation of resources as well as the betterment of patient care. This study sought to address the following question: "What are the direct, indirect (productivity), and overall costs associated with asthma?". Module 4: Evaluating Asthma Surveillance Download the Guide in PDF format pdf icon [PDF – KB] Module 5: Evaluation of Services and Health Systems Interventions Download the Guide in PDF format pdf icon [PDF – MB] Module 6: Economic Evaluation for State Asthma Programs Download the Guide in PDF format pdf icon [PDF – MB]. After reviewing your MONAHRQ-generated information for asthma, you may be ready to take steps to improve the quality of care in your area. The MyQI Improving Asthma Care Quality portal provides a framework, action steps, and resources for planning and implementing initiatives to improve the quality of care in the community, thereby reducing hospitalizations for asthma patients.   Formal economic evaluation is playing an increasingly important role in health-care decision-making. This is shown by the requirement to present economic data to support applications for public reimbursement for new pharmaceuticals in Australia and the provinces of Canada, and by the appraisal process initiated by the National Institute for Clinical Excellence in the U.K.